Category — Social Media
FDA’s Draft Guidance Regarding the Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Leaves Some Questions Unanswered
Feb. 3, 2012 – The FDA’s long-awaited draft Guidance for Industry on social media provides non-binding recommendations regarding how manufacturers and distributors of prescription drugs and medical devices can respond to unsolicited requests for off-label information, but does not provide guidelines for appropriate responses to other consumer inquiries or comments posted on Facebook and other electronic media. [Read more →]
February 3, 2012 Comments Off
Facebook Changes the Rules for Pharmaceutical Companies
Aug. 20, 2011 - Facebook recently decided to require pharmaceutical companies to enable commenting on their Facebook pages. With the new “open walls” policy, anyone can post comments for all to see on pharmaceutical company pages devoted to certain medical conditions and patient communities. Some pharmaceutical companies, including AstraZeneca and Johnson & Johnson, have responded by removing such pages. [Read more →]
August 20, 2011 Comments Off
